Secondary Polycythemia in Hepatocellular Carcinoma: Treat or No Treat
| Main Authors: | Setiawan, Poernomo Budi, Maimunah, Ummi, Siagian, Nenci |
|---|---|
| Format: | Article info application/pdf eJournal |
| Bahasa: | eng |
| Terbitan: |
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy
, 2020
|
| Subjects: | |
| Online Access: |
http://www.ina-jghe.com/journal/index.php/jghe/article/view/740 http://www.ina-jghe.com/journal/index.php/jghe/article/view/740/622 |
Daftar Isi:
- A 45-year man with a chronic hepatitis B virus (HBV) infection, elevated alphafetoprotein (AFP) 628ng/dL and Abdominal CT-scan features of Hepatocellular Carcinoma was admitted with polycythemia condition (haemoglobin 20.4g/dL, haematocrit 65.4%). Elevated of erythropoietin (EPO) serum level confirmed the polycythemia was because of HCC as a paraneoplastic syndrome. Based on diganosis criteria of HCC by PHPI 2017, the patient was diagnosed with HCC BCLC B and was treated with Trans arterial chemotherapy and embolization (TACE) with mixed doxorubicin. Aspirin 80mg once daily was given to patient to prevent thrombosis event. One month later after TACE, haemoglobin and haematocrite didn’t improve. Then 4 months later the patient died of cardiovascular event in the last admission at district hospital.